# A Study to Evaluate the Use of Memantine In Combination With Anti-HIV Drugs to Treat AIDS Dementia Complex (ADC)

> **NCT00000867** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 120 (—)

## Conditions studied

- AIDS Dementia Complex
- HIV Infections

## Interventions

- **DRUG:** Memantine

## Key facts

- **NCT ID:** NCT00000867
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1996-12
- **Primary completion:** —
- **Final completion:** 2001-07
- **Target enrollment:** 120 (—)
- **Last updated:** 2013-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000867

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000867, "A Study to Evaluate the Use of Memantine In Combination With Anti-HIV Drugs to Treat AIDS Dementia Complex (ADC)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00000867. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
